ArticleAsian Pacific journal of cancer prevention : APJCP2025
Expression of Interleukin 23 and Interleukin 28 in Mucinous & Non-Mucinous Colorectal Carcinoma and Their Relation to Clinicopathological Features and Prognosis.
Article in Asian Pacific journal of cancer prevention : APJCP, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionInterleukin (IL)-28, a type III interferon related to the IL-10 family, shares multiple structural and functional characteristics with IL-22, another member of the IL-10 cytokine family. Previous research identified IL-22 as a downstream effector of IL-23 in colorectal tumorigenesis. However, data on IL-28 expression in colorectal cancer (CRC) and its relation to clinicopathological features, prognosis, and IL-23 expression remain limited.
methodsIL-23 and IL-28 immunohistochemical reactivity was evaluated in 75 specimens of colorectal mucinous adenocarcinoma (MA) and 75 specimens of non-mucinous adenocarcinoma (NMA) using the high-density manual tissue microarray method. Clinicopathological features and survival data were statistically analyzed.
resultsMA exhibited higher IL-28 and IL-23 expression than NMA; however, this was statistically significant only for IL-23. IL-23 and IL-28 positivity rates showed a highly significant interrelation in MA only. Within the NMA group, no significant association was observed between IL-23 or IL-28 expression and clinicopathological features or survival. In the MA group, high IL-23 expression was significantly associated with positive lymphovascular invasion, advanced pathological tumor (pT) stage, late TNM stage, and decreased disease-free survival and overall survival. High IL-28 expression was significantly associated with advanced pT stage, lymph node spread, advanced TNM stage, and decreased disease-free survival and overall survival.
conclusionFor the first time, the expression of IL-23 and IL-28 has shown a highly significant interrelation in MA patients, suggesting a possible interplay between them. High IL-23 and IL-28 expressions may have adverse prognostic effects on survival in MA. Molecular studies are necessary to further investigate the interaction between IL-23 and IL-28 in CRC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.